Topcon
7732
TEMONA
3985
Forside
2330
Okamoto Glass
7746
Delta-Fly Pharma
4598
(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 0.05%15.69B | 15.07%69.37B | 3.54%17.06B | 30.02%20.62B | 2.75%16.01B | 26.79%15.68B | 3.93%60.28B | 8.15%16.47B | -3.63%15.86B | 14.66%15.58B |
Cost of revenue | -0.39%13.38B | 10.36%56.53B | -0.72%14.48B | 11.26%15.3B | 8.61%13.32B | 26.43%13.43B | 5.06%51.23B | 11.40%14.59B | 0.26%13.75B | 7.66%12.26B |
Gross profit | 2.67%2.31B | 41.74%12.83B | 36.39%2.58B | 152.85%5.32B | -18.90%2.69B | 29.00%2.25B | -2.03%9.05B | -11.73%1.89B | -23.20%2.1B | 51.02%3.32B |
Operating expense | 7.74%1.1B | 25.53%4.93B | 39.13%1.47B | 48.13%1.47B | 0.00%969M | 12.32%1.02B | 14.40%3.93B | 6.01%1.06B | 20.17%989M | 24.07%969M |
Operating profit | -1.54%1.21B | 54.15%7.91B | 32.89%1.1B | 245.91%3.85B | -26.69%1.72B | 47.13%1.23B | -11.74%5.13B | -27.26%830M | -41.85%1.11B | 65.89%2.35B |
Net non-operating interest income (expenses) | -1M | 0.00%-4M | 25.00%-3M | -1M | 0 | 0 | 73.33%-4M | -33.33%-4M | 0 | 75.00%-1M |
Non-operating interest income | --0 | --0 | --0 | --0 | --0 | --0 | 0.00%1M | --0 | --0 | --0 |
Non-operating interest expense | --1M | -20.00%4M | -25.00%3M | --1M | --0 | --0 | -68.75%5M | 33.33%4M | --0 | -75.00%1M |
Net investment income | 32.88%97M | -1.02%194M | 5.56%19M | -5.48%69M | 37.50%33M | -9.88%73M | 25.64%196M | 0.00%18M | 23.73%73M | 4.35%24M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 6,400.00%189M | 0 | 0 | 141M | 48M | -175.00%-3M | -3M | 0 | 0 |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -2,000.00%-19M | 0.00%-49M | -38.89%-50M | 0 | 0 | 1M | -58.06%-49M | -3,500.00%-36M | -700.00%-8M | 16.67%-5M |
Less:Other special charges | 2,000.00%19M | 25.64%49M | 92.31%50M | --0 | --0 | ---1M | 25.81%39M | 2,500.00%26M | 700.00%8M | ---- |
Less:Write off | ---- | --0 | ---- | ---- | ---- | ---- | --10M | ---- | ---- | ---- |
Other non-operating income (expenses) | -80.00%2M | -450.94%-186M | -90.00%2M | -1,316.67%-219M | 61.54%21M | 400.00%10M | 32.50%53M | 400.00%20M | 63.64%18M | 30.00%13M |
Income before tax | -5.50%1.29B | 51.28%8.05B | 29.85%1.07B | 208.94%3.7B | -19.50%1.92B | 48.42%1.36B | -10.80%5.32B | -29.27%824M | -39.45%1.2B | 65.39%2.38B |
Income tax | -6.36%412M | 66.16%2.5B | 537.21%274M | 230.90%1.18B | -21.98%607M | 34.56%440M | -3.34%1.5B | 26.47%43M | -42.77%356M | 70.99%778M |
Net income | -5.19%876M | 45.45%5.55B | 2.05%796M | 199.29%2.52B | -18.24%1.31B | 56.08%924M | -13.43%3.82B | -30.97%780M | -37.91%842M | 62.70%1.6B |
Net income continuous operations | -5.09%877M | 45.41%5.55B | 1.92%796M | 199.64%2.52B | -18.29%1.31B | 56.08%924M | -13.43%3.82B | -30.95%781M | -37.93%841M | 62.80%1.6B |
Noncontrolling interests | -34.75%154M | 61.92%1.2B | -56.80%143M | 376.80%596M | -22.26%220M | 23,700.00%236M | -26.27%738M | 0.00%331M | -56.75%125M | 133.88%283M |
Net income attributable to the company | 5.09%722M | 41.50%4.35B | 45.11%653M | 168.85%1.93B | -17.37%1.09B | 15.85%687M | -9.66%3.08B | -43.75%450M | -32.90%716M | 52.90%1.32B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 5.09%722M | 41.50%4.35B | 45.11%653M | 168.85%1.93B | -17.37%1.09B | 15.85%687M | -9.66%3.08B | -43.75%450M | -32.90%716M | 52.90%1.32B |
Gross dividend payment | ||||||||||
Basic earnings per share | 5.02%26.535 | 41.50%159.975 | 45.17%23.99 | 168.87%70.725 | -17.38%39.9925 | 15.81%25.2675 | -9.65%113.055 | -43.76%16.525 | -32.86%26.305 | 52.81%48.4075 |
Diluted earnings per share | 5.02%26.535 | 41.50%159.975 | 45.17%23.99 | 168.88%70.7219 | -17.38%39.9925 | 15.81%25.2675 | -9.65%113.055 | -43.76%16.525 | -32.86%26.3024 | 52.89%48.4075 |
Dividend per share | 0 | 160.00%91 | 167.50%53.5 | 0 | 150.00%37.5 | 0 | 0.00%35 | -42.86%20 | 0 | 15 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |